造血干细胞移植患者服药自我管理的研究进展  

Research progress of medication sel-management in patients with hematopoietic stem cell transplantation

作　　者：潘政雯 周晓瑜[1] 周玮炜 许丽炜[1] 章建丽[1] 严月霞[1] PAN Zhengwen;ZHOU Xiaoyu;ZHOU Weiwei;XU Liwei;ZHANG Jianli;YAN Yuexia

机构地区：[1]洪浙江大学医学院附属第一医院骨髓移植中心,杭州市3100033

出　　处：《中华急危重症护理杂志》2023年第8期760-764,共5页Chinese Journal of Emergency and Critical Care Nursing

基　　金：浙江大学医学院附属第一医院护理学科建设科研专项基金(2023ZYHL019)。

摘　　要：服药自我管理强调患者准备和使用药物,并在一段时间内维持药物安全使用,以成功管理自身治疗方案,可影响造血干细胞移植患者的短期和长期预后。准确评估患者的服药依从性,可帮助医护人员了解患者用药的适当性、有效性和安全性,及时调整治疗方案,也可为造血干细胞移植患者制订服药自我管理方案提供依据。该文从造血干细胞移植患者服药自我管理的影响因素、评估工具及干预策略3方面对造血干细胞移植患者服药自我管理进行综述,以期为开展相关研究提供参考。Medication self-management emphasizes patient preparation and use of medication,and maintains safe use of drugs for a period of time to scessfully manage their own treatment plan,which can affect the short-lerm and long-term prognosis of patients undergoing hematopoietic stem cell transplantation(HSCT).Accurate assessment of patient medication compliance can help medical staff understand the appropriateness,efetiveness and safety of patient medication,adjust the treatment plan in time,and also provide a basis for the formulaion of medication self-management plan for patients with HSCT.This article reviews the influencing factons,evaluation and intervention strategies of medication sel-management in patients with HSCT,in order to provide a reference for related research.

关 键 词：造血干细胞移植 自我遵瞩服药 自我管理 景影响因素 纯综述文献(主题) 

分 类 号：R473[医药卫生—护理学]